Rafael Holdings Inc. Class B (RFL)
$1.40
$0.05
(3.33%)
As on 04-Jun-2026 12:44EDT
Market cap
$72 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-33 Mln
-
ROE
-0.4 %
-
ROCE
-- %
-
Industry P/E
36.83
-
EV/EBITDA
5.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
51,224,977
9 Years Aggregate
CFO
$-64.30 Mln
EBITDA
$-27.98 Mln
Net Profit
$-174.82 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rafael Holdings Inc. Class B (RFL)
| 18.2 | 12.5 | -3.8 | -1.8 | -14.6 | -50.4 | -- |
|
BSE Sensex
| -12.2 | -3.3 | -7.3 | -7.9 | 5.9 | 7.3 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Rafael Holdings Inc. Class B (RFL)
| -27.5 | -9.8 | -2.1 | -63.3 | -78.1 | 30.7 | 125.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rafael Holdings Inc. Class B (RFL)
|
1.4 | 72.3 | 1.2 | -33.1 | -2,975.9 | -39.1 | -- | 0.9 |
| 42.2 | 86.2 | 21.8 | -0.9 | -5.5 | -1.6 | -- | 1.6 |
Shareholding Pattern
View DetailsAbout Rafael Holdings Inc. Class B (RFL)
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate.... The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey. Read more
-
Founder & Executive Chairman
Mr. Howard S. Jonas
-
Founder & Executive Chairman
Mr. Howard S. Jonas
-
Headquarters
Newark, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Rafael Holdings Inc. Class B (RFL)
What is the current share price of Rafael Holdings Inc Class B (RFL) Today?
The share price of Rafael Holdings Inc Class B (RFL) is $1.40 (NYSE) as of 04-Jun-2026 12:44 EDT. Rafael Holdings Inc Class B (RFL) has given a return of -14.59% in the last 3 years.
What is the current PB & PE ratio of Rafael Holdings Inc Class B (RFL)?
Since, TTM earnings of Rafael Holdings Inc Class B (RFL) is negative, P/E ratio is not available.
The P/B ratio of Rafael Holdings Inc Class B (RFL) is 0.90 times as on 29-May-2026, a 19 discount to its peers’ median range of 1.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
What is the 52 Week High and Low of Rafael Holdings Inc Class B (RFL)?
The 52-week high and low of Rafael Holdings Inc Class B (RFL) are Rs 3.19 and Rs 1.12 as of 04-Jun-2026.
What is the market cap of Rafael Holdings Inc Class B (RFL)?
Rafael Holdings Inc Class B (RFL) has a market capitalisation of $ 72 Mln as on 29-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Rafael Holdings Inc Class B (RFL)?
Before investing in Rafael Holdings Inc Class B (RFL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.